Markets:

Overview

News

Currencies

International

Treasuries

Allarity Therapeutics, Inc. - Common stock (NQ:ALLR)

1.190 -0.080 (-6.30%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Allarity Therapeutics, Inc. - Common stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday ↗

November 03, 2022

Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 19, 2022

On Wednesday, 200 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

October 27, 2022

On Thursday, 111 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 26, 2022

On Wednesday, 53 companies reached new 52-week lows.

Via Benzinga

Precision Medicine Could Get Even More Precise With Allarity Therapeutics’ “Next-Generation” Diagnostics Platform

October 18, 2022

By Rachael Green, Benzinga

Via News Direct

Precision Medicine Could Get Even More Precise With Allarity Therapeutics’ “Next-Generation” Diagnostics Platform

October 18, 2022

Once brought into its pipeline, Allarity uses its DRP® platform to develop companion diagnostics alongside each drug to improve the treatments in a personalized medicine approach. Earlier this year,...

Via TheNewswire.com

Stocks That Hit 52-Week Lows On Tuesday ↗

October 25, 2022

On Tuesday, 120 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 17, 2022

Gainers Cyclerion Therapeutics (NASDAQ:CYCN) shares increased by 10.8% to $0.39 during Monday's after-market session. The market value of their outstanding shares is at $16.8 million.

Via Benzinga

Precision Medicine Could Get Even More Precise With Allarity Therapeutics' "Next-Generation" Diagnostics Platform ↗

October 17, 2022

Allarity Therapeutics Inc. (NASDAQ: ALLR) is a clinical-stage pharmaceutical company focused on oncology treatments.

Via Benzinga

Why Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday's Mid-Day Session ↗

October 14, 2022

Gainers Intelligent Living Application Group Inc. (NASDAQ: ILAG) surged 77.7% to $9.35.

Via Benzinga

Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday ↗

October 17, 2022

Gainers Agrify Corporation (NASDAQ: AGFY) climbed 53.8% to close at $1.45. FedNat Holding Company (NASDAQ: FNHC) gained 48% to settle at $0.52.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 13, 2022

Gainers

Via Benzinga

Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday ↗

October 14, 2022

Gainers Nutex Health Inc. (NASDAQ: NUTX) jumped 72.4% to settle at $0.9551 on Thursday. Nutex Health recently provided a corporate update.

Via Benzinga

Allarity Therapeutics Reports Second Quarter 2022 Financial Results, Provides Recent Operational Highlights, and Regains Compliance with NASDAQ Listing Requirements

October 11, 2022

From Allarity Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 14, 2022

Via Benzinga

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday ↗

September 09, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 31, 2022

Via Benzinga

Why Several Chinese Stocks Traded Higher; Here Are 58 Biggest Movers From Yesterday ↗

August 26, 2022

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) surged 95.3% to close at $0.2580 on Thursday after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target...

Via Benzinga

Why Snowflake Is Trading Higher By 20%, Here Are 51 Stocks Moving In Thursday's Mid-Day Session ↗

August 25, 2022

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 91% to $0.2530 after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target of $6.50.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 25, 2022

Via Benzinga

Why Splunk Is Trading Lower By Around 10%; Here Are 28 Stocks Moving Premarket ↗

August 25, 2022

Gainers ECMOHO Limited (NASDAQ: MOHO) shares rose 47% to $0.2149 in pre-market trading.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 25, 2022

We're starting off the day with an overview of the biggest pre-market stock movers for Thursday and the news behind that movement!

Via InvestorPlace

Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday ↗

August 24, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 23, 2022

Via Benzinga

Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session ↗

August 23, 2022

Gainers

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2022 ↗

August 23, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 23, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 19, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

August 19, 2022

We're starting the final day of trading this week with a look at the biggest pre-market stock movers for Friday and what's moving them!

Via InvestorPlace

This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday ↗

August 19, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.